The PI3K/Akt pathway upregulates Id1 and integrin α4 to enhance recruitment of human ovarian cancer endothelial progenitor cells

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Su, Yajuan ^a   Zheng, Lei ^a   Wang, Qian ^a   Bao, Jie ^a   Cai, Zhen ^a   Liu, Ailan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALPHA4 INTEGRIN; DOUBLE STRANDED DNA; GREEN FLUORESCENT PROTEIN; INHIBITOR OF DIFFERENTIATION 1; LENTIVIRUS VECTOR; MATRIGEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA; ID1 PROTEIN, HUMAN; MESSENGER RNA; SMALL INTERFERING RNA;

ARTICLE; CANCER STEM CELL; CELL ADHESION; CELL ASSAY; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OVARY CANCER; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ADOLESCENT; ADULT; CASE CONTROL STUDY; CELL MOTION; COLLOID CARCINOMA; COMPARATIVE STUDY; CYSTADENOCARCINOMA; DRUG ANTAGONISM; ENDOMETRIUM TUMOR; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; OVARY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; STEM CELL;

ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; INTEGRIN ALPHA4; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STEM CELLS; UP-REGULATION; YOUNG ADULT;

EID: 77955971234     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-459     Document Type: Article

References (23)

1. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K, Benezra R. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999, 401(6754):670-677. 10.1038/44334, 10537105.
2. Bertolini F, Shaked Y, Mancuso P, Kerbel RS. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nature Reviews Cancer 2006, 6(11):835-845. 10.1038/nrc1971, 17036040.
3. Young PP, Vaughan DE, Hatzopoulos AK. Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 2007, 49(6):421-429. 10.1016/j.pcad.2007.02.004, 1978244, 17498522.
4. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006, 20(9):1495-1497. 10.1096/fj.05-5137fje, 16754748.
5. Stoelting S, Trefzer T, Kisro J, Steinke A, Wagner T, Peters SO. Low-dose oral metronomic chemotherapy prevents mobilization of endothelial progenitor cells into the blood of cancer patients. In Vivo 2000, 822(6):831-836.
6. Perk J, Gil-Bazo I, Chin Y, de Candia P, Chen John JS, Zhao Y, Chao S, Cheong W, Ke Y, Al-Ahmadie H, Gerald William L, Brogi E, Benezra R. Reassessment of Id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-Id1 antibody. Cancer Res 2006, 66(22):10870-10877. 10.1158/0008-5472.CAN-06-2643, 17108123.
7. Shaked Y, Ciarrocchi A, Franco M, Lee CR, Man S, Cheung AM, Hicklin DJ, Chaplin D, Foster FS, Benezra R, Kerbel RS. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006, 313(5794):1785-1787. 10.1126/science.1127592, 16990548.
8. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008, 319(5860):195-198. 10.1126/science.1150224, 18187653.
9. Maw MK, Fujimoto J, Tamaya T. Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer 2009, 10(9):430.
10. Zhang X, Ling MT, Feng H, Wong YC, Tsao SW, Wang X. Id-I stimulates cell proliferation through activation of EGFR in ovarian cancer cells. Br J Cancer Dec 2004, 91(12):2042-2047.
11. Lorusso D, Ferrandina G, Graggi S, Gadduci A, Pignata S, Tateo S, Bia-monte R, Manzione L, Di Vagno G, Ferrau F, Scambia G. Phase III multicenter randomized trial of amifostine as cytoprotect-ant in first-line chemotherapy in ovarian cancer patients. Ann Oncol 2003, 14(7):1086-1093. 10.1093/annonc/mdg301, 12853351.
12. Melichar B, Urbanek L, Krcmova L, Kalabova H, Svobodova I, Drag-ounova E, Vesely P, Hyspler R, Solichova D. Urinary neopterin in patients with ovarian cancer. Pteridines 2006, 17(4):145-153.
13. Spannuth WA, Sood AK, Coleman RL. Angiogenesis as a strategic target for ovarian cancer therapy. Nat Clin Pract Oncol 2008, 5(4):194-204. 10.1038/ncponc1051, 18268546.
14. Khan ZA, Melero-Martin JM, Wu X, Paruchuri S, Boscolo E, Mulliken JB, Bischoff J. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 2006, 108(3):915-921. 10.1182/blood-2006-03-006478, 1895853, 16861344.
15. Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S, Kenessey I, Ostoros G, Magyar M, Ladanyi A, Bogos K, Tovari J. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 2006, 66(14):7341-7347. 10.1158/0008-5472.CAN-05-4654, 16849585.
16. Khoo CP, Pozzilli P, Alison MR. Endothelial progenitor cells and their potential therapeutic applications. Regen Med 2008, 3(6):863-876. 10.2217/17460751.3.6.863, 18947309.
17. de Candia P, Benera R, Solit DB. A role for Id proteins in mammary gland physiology and tumorigenesis. Adv Cancer Res 2004, 92:81-94. full_text, 15530557.
18. Shaked Y, Ciarrocchi A, Franco M, Lee Christina R, Man S, Cheung Alison M, Hicklin Daniel J, Chaplin D, Stuart Foster F, Benezra R, Kerbel Robert S. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006, 313(5794):1785-1787. 10.1126/science.1127592, 16990548.
19. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001, 7(11):1194-1201. 10.1038/nm1101-1194, 11689883.
20. Ciarrocchi A, Jankovic V, Shaked Y, Nolan DJ, Mittal V, Kerbel RS, Nimer SD, Benezra R. Id1 restrains p21 expression to control endothelial progenitor cell formation. PLoS One 2007, 2(12):e1338. 10.1371/journal.pone.0001338, 2129121, 18092003.
21. Qian Y, Chen X. ID1, inhibitor of differentiation/DNA binding, is an effector of the p53-dependent DNA damage response pathway. J Biol Chem 2008, 283(33):22410-22416. 10.1074/jbc.M800643200, 2504896, 18556654.
22. Benezra R, Rafii S, Lyden D. The Id proteins and angiogenesis. Oncogene 2001, 20(58):8334-8341. 10.1038/sj.onc.1205160, 11840326.
23. Jin H, Aparna A, Su J, Per B, Dwayne S, Martin F, Varner J. A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. The Journal of Clinical Investigation 2006, 116(3):652-662. 10.1172/JCI24751, 1378185, 16498499.